A joint statement from the UK government and the European Union signals the latest attempt to draw a line under a long-running dispute over vaccine supplies in Europe.
The UK and EU said they have been “discussing what more we can do to ensure a reciprocally beneficial relationship between the UK and EU on COVID-19.”
In February, with the vaccine rollout proceeding slowly in Europe, officials threatened to block exports from the 27-nation trading bloc, raising concerns over so-called “vaccine nationalism.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze